Supplemental Information The miR-1792 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells

1. SUPPLEMENTAL DATA  Figure S1: Gemcitabine resistant cells are enriched for CSCs, related to Figure 1  Figure S2: Slow cycling cells possess CSC phenotype, related to Figure 2.  Figure S3: miR-17-92 downregulation in spheres and in gemcitabine resistant cells, related to Figure 3.  Figure S4: miR-17-92 overexpression impairs CSC phenotype, related to Figure 4.  Figure S5: miR-17-92 targets* multiple members of Nodal/TGFb signalling, related to Figure 5.  Figure S6: Knockdown of p21 or TBX3 inhibits cancer stem cell phenotype, related to Figure 6.  Figure S7: In vivo overexpression of miR-17-92 reverses quiescence and chemoresistance, related to Figure 7  Table S1: Table of utilized primer sequences for real-time RT-qPCR